First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: Omnicell: the story is balanced — Hospital capital equipment spending trends - influenced by Medicare reimbursement rates, hospital operating margins…
★ Analysts see FY2026 revenue reaching $1.2B — +4.5% growth in a single year.
What Moves the Stock
1Hospital capital equipment spending trends - influenced by Medicare reimbursement rates, hospital operating margins, and elective procedure volumes
2Recurring revenue growth rate and mix shift toward software subscriptions (target 40%+ of revenue)
3New product adoption: Autonomous mobile robots for medication delivery, cloud-based central pharmacy management systems
4Large enterprise contract wins with integrated delivery networks (IDNs) and group purchasing organizations (GPOs)
5Margin expansion trajectory as company exits hardware-heavy legacy products and scales SaaS platform
6Product revenue (~60-65% estimated): Automated dispensing cabinets, central pharmacy robotics, IV compounding systems sold to hospitals and health systems
7Service and other revenue (~35-40% estimated): Software subscriptions, maintenance contracts, professional services, consumables for medication adherence packaging
8Medication adherence solutions: Packaging equipment and services for retail/mail-order pharmacies
growth - Investors focus on recurring revenue transition story and long-term margin expansion potential from 0.4% to mid-teens operating…
Rising rates negatively impact Omnicell through two channels: (1) Higher cost of capital for hospital customers delays large automation…
Watch on earnings: Hospital capital equipment spending index and healthcare system operating margins, Recurring revenue growth rate and percentage of total revenue (target 40%+), Federal funds rate and 10-year Treasury yield (impacts customer financing decisions and valuation multiples).
One Sentence Summary:
Omnicell: the story is balanced — hospital capital equipment spending trends - influenced by medicare reimbursement rates, hospital operating margins.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.